← Open Payments lookup

JESSICA CHU: Open Payments

NPI 1063076586 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,232 in 61 payments from 18 companies in 2025. Trend: 2023 $257 · 2024 $2,049 · 2025 $1,232

Food & beverage: $1,232
CompanyPaymentsAmount
Novo Nordisk Inc17$310
Dexcom, Inc.6$228
Xeris Pharmaceuticals, Inc.5$108
Lilly USA, LLC7$104
Amgen Inc.4$89
BETA BIONICS, INC.6$88
Corcept Therapeutics2$45
SANOFI-AVENTIS U.S. LLC2$44
Medtronic, Inc.3$43
RECORDATI_RARE_DISEASES_INC.1$23

Products named: Ozempic, Dexcom G6 Transmitter, MOUNJARO, iLet Bionic Pancreas, GVOKE HYPOPEN, TEPEZZA, Korlym, TZIELD.

Industry payments across LA — which companies pay providers there.